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a  b  s  t  r  a  c  t
ATP-binding  cassette  transporter  A1  mediates  the export  of  excess  cholesterol  from  macrophages,  con-
tributing  to the  prevention  of  atherosclerosis.  Advanced  glycated  albumin  (AGE-alb)  is prevalent  in
diabetes  mellitus  and  is  associated  with  the development  of  atherosclerosis.  Independently  of  changes  in
ABCA-1  mRNA  levels,  AGE-alb  induces  oxidative  stress  and  reduces  ABCA-1  protein  levels,  which  leads  to
macrophage  lipid  accumulation.  These  metabolic  conditions  are  known  to  elicit  endoplasmic  reticulum
(ER)  stress.  We  sought  to  determine  if AGE-alb  induces  ER  stress  and  unfolded  protein  response  (UPR)
in  macrophages  and  how  disturbances  to  the  ER  could  affect  ABCA-1  content  and  cholesterol  efﬂux  in
macrophages.  AGE-alb  induced  a  time-dependent  increase  in  ER  stress  and UPR markers.  ABCA-1  content
and cellular  cholesterol  efﬂux  were  reduced  by  33%  and  47%,  respectively,  in  macrophages  treated  with
AGE-alb,  and  both  were  restored  by  treatment  with  4-phenyl  butyric  acid  (a chemical  chaperone  that  alle-
viates  ER  stress),  but not  MG132  (a proteasome  inhibitor).  Tunicamycin,  a classical  ER  stress  inductor,  also
impaired  ABCA-1  expression  and  cholesterol  efﬂux  (showing  a  decrease  of 61%  and  82%, respectively),
conﬁrming  the  deleterious  effect  of ER  stress  in macrophage  cholesterol  accumulation.  Glycoxidation
induces  macrophage  ER  stress,  which  relates  to the  reduction  in  ABCA-1  and  in reverse  cholesterol  trans-
port, endorsing  the adverse  effect  of  macrophage  ER  stress  in  atherosclerosis.  Thus,  chemical  chaperones
that  alleviate  ER  stress  may  represent  a  useful  tool  for  the  prevention  and  treatment  of  atherosclerosis
in  diabetes.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
In diabetes mellitus (DM), cardiovascular disease is the major
cause of morbidity and mortality (Earl, 2011). In particular, alter-
ations along the reverse cholesterol transport (RCT) system that
are associated with the development of atherosclerosis have been
described in DM (Tan, 2009). The RCT system allows excess
Abbreviations: ABCA-1, ATP binding cassette transporter class A type I; ABCG-
1, ATPbinding cassette transporter class G type I; AGE, advanced glycation end
products; AGE-alb, advanced glycated albumin; Apo A-I, apolipoprotein A-I; ATF6,
activating transcription factor 6; CML, carboxymethyllysine; DM, diabetes melli-
tus; eIf2˛, eukaryotic translation initiation factor2 subunit 1alpha; ER,  endoplasmic
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Grp78,  glucose-regulated protein 78 kDa; Grp94,  glucose-regulated protein 94 kDa;
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acid; RAGE, receptor for advanced glycation end-products; ROS, reactive oxygen
species; Tun, tunicamycin; UPR, unfolded protein response.
∗ Corresponding author at: Lipids Laboratory (LIM 10), Faculty of Medical Sci-
ences, University of São Paulo, Av Dr Arnaldo 455 Room 3305, CEP 01246-000, SP,
Brazil. Tel.: +55 11 30617263; fax: +55 11 30617263.
E-mail address: mpassere@usp.br (M.  Passarelli).
of cholesterol to be removed from arterial macrophages by lipid-
free Apo A-I and HDL and then transported to the liver for bile
excretion. The removal of cellular cholesterol is mainly driven
by the ATP cassette transporter type 1 (ABCA-1) which mediates
cholesterol export to plasma Apo A-I by utilizing free energy from
ATP hydrolysis (Tang and Oram, 2009). ABCA-1 is a short-lived,
220 kDa plasma membrane protein. Its expression and activity are
primarily regulated by the oxysterols-activated liver X receptor
(LXR), although posttranslational modiﬁcations also inﬂuence its
ﬁnal protein content (Tall et al., 2002; Wellington et al., 2002).
In DM,  cellular stressors, including reactive oxygen species
(ROS), inﬂammatory cytokines, hexosamine pathway derivatives
and lipid accumulation, lead to endoplasmic reticulum (ER) stress.
ER stress is known to activate the unfolded protein response (UPR)
as an adaptive response to the accumulation of misfolded pro-
teins in the lumen of the organelle (Ron and Walter, 2007). During
the UPR, sequential activation of ER-resident proteins mediates a
cascade of events that promote cell adaptation and survival. As a
short-term response, cell translational machinery is shut off via
PERK-mediated phosphorylation of eIF2, which helps to prevent
the entrance of additional misfolded proteins into the ER. Next,
1357-2725/$ – see front matter ©  2012 Elsevier Ltd. All rights reserved.
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IRE1 and ATF6 activation lead to an increase in the expression
of Grp78 and Grp94 chaperones, and subsequently triggers an
antioxidant defense that aids in the proper folding of proteins. In
addition, unfolded proteins are continuously cleared by ubiquitina-
tion and proteasomal cleavage in a process known as endoplasmic
reticulum-associated degradation (ERAD). Finally, if translational
homeostasis is not satisfactorily achieved, the pro-apoptotic ATF-
6/CHOP-mediated pathway can be elicited, resulting in cell death
(Zhang and Kaufman, 2008). In both humans and animal models,
UPR markers are enhanced in atherosclerotic lesions and have also
been associated with plaque instability and rupture in atheroscle-
rosis (Myoishi et al., 2007; Zhou et al., 2005; Tsukano et al., 2010).
Advanced glycation end products (AGE) are prevalent in DM
and mainly associate with serum albumin (AGE-alb), which corre-
sponds to 80% of the total glycated proteins in circulation (Cohen,
2003). AGE-alb enhances ROS generation and induces intracellu-
lar lipid accumulation by impairing the expression of ABCA-1 (de
Souza Pinto et al., 2012). However, this effect is not related to
alterations in ABCA-1 gene transcription or mRNA levels (Passarelli
et al., 2005; Isoda et al., 2007). Considering that the activation of
ER stress following AGE-alb treatment has not been reported in
macrophages, the aim of this study was to evaluate whether ER
stress mediates the reduction in ABCA-1 protein expression and in
cholesterol efﬂux induced by AGE-alb. In addition, we  sought to
assess the effect of a chemical chaperone that alleviates ER stress
(4-phenyl butyric acid; 4-PBA) on ABCA-1 cell content and choles-
terol efﬂux. Understanding how ER stress modulates ABCA-1 levels
in cells under glycoxidative stress will help to elucidate the role of
hyperglycemia in foam cell formation in DM.
2. Material and methods
2.1. Preparation of AGE-albumin
AGE-alb was prepared by incubating fatty acid free albumin
(FAFA, 40 mg/mL) with 10 mM glycolaldehyde (GAD; Sigma Chem.
Com. St. Louis, MO)  for 4 days, at 37 ◦C under sterile conditions and
a nitrogen atmosphere in a water bath shaker in the dark. Control
albumin (C-alb) was prepared under the same conditions, how-
ever incubated with PBS only. After extensive dialysis, the samples
were sterilized in a 0.22 m ﬁlter. All albumin samples contained
<50 pg endotoxin/mL as determined using the chromogenic Limu-
lus amebocyte assay (Cape Cod, Falmouth, MA).
2.2. AGE determination in albumin samples
The determination of AGE in albumin samples was  performed
according to Pageon et al. (2007).  Brielﬂy, AGE and C-alb samples
were diluted to 1 mg/mL  and ﬂuorescence intensity was  measured
at 440 nm ( emission) and 370 nm ( excitation).
2.3. Cell culture
Mouse peritoneal macrophages were harvested after the injec-
tion of 6 mL  of PBS into the peritoneal cavity. After a soft abdominal
massage, cells were collected into sterile tubes, centrifuged and
resuspended in RPMI 1640 containing 10% fetal calf serum (FCS),
1% penicillin–streptomycin and 4 mM l-glutamine. The cells were
then plated in Petri dishes or 48 well-plates. J774 cells (a tumoral
murine macrophage cell line) were cultured in RPMI 1640 con-
taining 10% FCS, 1% penicillin–streptomycin and 4 mM l-glutamine
and maintained in a 5% CO2 incubator at 37 ◦C. During the different
experimental treatments described below, cells were maintained
in DMEM, and cell viability was assured by exclusion of trypan blue
(higher than 99%) and lactate dehydrogenase release to cell culture
medium (In vitro toxicology assay kit, Sigma Aldrich, St Louis, MO,
USA) in all experimental conditions. No change in apoptosis was
observed after exposure to AGE-alb, as assessed by the number of
Annexin V-FITC positive cells (data not shown).
2.4. Assessment of carbonyl content in macrophages
To determine the carbonyl content in macrophages, lysates
from C or AGE-alb-treated cells were incubated with 10 mM of
dinitrophenilhydrazine in 2.5 M HCl for 1 hour at room tem-
perature. The reaction was blocked by the addition of 20%
trichloroacetic acid (TCA). The pellets were washed twice with
absolute ethanol/ethylacetate (1:1) and once with 10% TCA. The
protein pellets were dissolved in 6 M guanidine hydrochloride and
the absorption at 370 nm was  determined. Carbonyl content was
calculated using the molar absorption coefﬁcient of aliphatic hydra-
zones of 22,000 M−1 cm−1 and expressed as nanomoles carbonyl
per milligram of protein.
2.5. Immunoblotting
Mouse peritoneal macrophages were treated with C- or AGE-alb
for different intervals and were also treated with C- or AGE-alb in
the absence or presence of 2.5 or 5.0 mM 4-PBA (Alpha Aeser, Ward
Hill, MA). Following treatment, cells were scraped into Tris buffered
saline containing protease inhibitors, and equal amounts of cel-
lular protein were applied to a polyacrylamide gel (SDS-PAGE).
The expressions of Grp78, Grp94, eIF2-P, ATF-6, ubiquitin, PDI,
CHOP and -actin were determined using the following antibodies,
respectively: anti-KDEL (Stressgen, Ann Arbor, MI, EUA), anti-
eIf2-P (Upstate Biotechnology), anti-ATF6 (Abcam, Cambridge,
MA,  EUA), anti-ubiquitin (ZYMED® Laboratories Carlsbad, CA, EUA),
anti-PDI (Stressgen), anti-CHOP (ABR-Afﬁnity Bioreagents, Fisher
Scientiﬁc, USA) and anti--actin (Fitzgerald Industries Interna-
tional Inc., Concord, MA). Tunicamycin (2 g/mL) was used as
a positive control for the induction of ER stress. Proteins were
detected with horseradish peroxidase-conjugated antibodies and
an enhanced chemiluminescence reagent (Pierce, Rockford, IL).
Immunoblot band density was  quantiﬁed using an ImageQuant
300 Imager (GE Healthcare), and differences between the bands
were analyzed in pixels, using the ImageQuant TL software (GE
Healthcare). The results were expressed as arbitrary units, analyzing
AGE-alb versus C-alb normalized to -actin expression.
2.6. ABCA-1 protein content
Due to the need for a higher number of cells, J774 macrophages
were used in ﬂow cytometry assays instead of mouse peritoneal
macrophages. J774 macrophages were pre-incubated with 0.5 mM
8-bromoadenosine-3′, 5′-cyclic monophosphate (cAMP) (Sigma
Aldrich) and were treated for 8 h with C- or AGE-alb in the pres-
ence or absence of the ER stress inhibitor 4-PBA (2.5 or 5.0 mM)
or the proteasome inhibitor MG132 (1 M).  MG132 was  added
to the culture in the last 2 h of incubation with albumins, while
4-PBA was  added simultaneously with the albumins In some incu-
bations, cells were treated with tunicamycin (2 g/mL for 18 h).
To assess the ABCA-1 content on the macrophage surface, a total
of 1 × 106 cells were trypsinized, washed extensively with PBS
and ﬁxed in 4% paraformaldehyde. After ﬁxation, cells were incu-
bated with anti-ABCA-1 antibody (Novus Biologicals, Inc., Littleton,
CO – 1:250 dilution) for 1 h at room temperature, rinsed in PBS
and incubated with 4 g/mL Alexa Fluor 488 antibody (Invitro-
gen, USA). Cellular ﬂuorescence intensity was  evaluated by ﬂow
cytometry using a FACS Calibur and Cellquest Software (B.D., San
Jose, CA). All of the conditions were corrected to basal cellular
ﬂuorescence (cells without antibody labeling). The total cellular
ABCA-1 content was determined by immunocytochemistry. Brieﬂy,
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Fig. 1. Increased expression of ER stress and UPR markers in macrophages treated with AGE-alb. Mouse peritoneal macrophages were treated for different periods of time
with  C-, AGE-alb (2 mg/mL) or tunicamycin (Tun-2 g/mL). Equal amounts of cellular protein were loaded onto polyacrylamide gels, and electrophoresis and immunoblotting
were  performed to measure the expression of (A) Grp78 (8 h treatment); (B) Grp78 (2–18 h); (C) Grp94 (2–18 h); (D) ATF6 (2–18 h) and (E) eIF2-P (2–18 h). Data are expressed
as  arbitrary units corrected to -actin levels (representative ﬁgure from two  independent experiments).
mouse peritoneal macrophages were seeded on coated cover slips
and allowed to adhere for 2 days. After pre-treatment with 0.5 mM
cAMP macrophages were incubated with C- or AGE-alb for 8 h in the
presence or absence of 4-PBA and MG132. Cells were then washed
with PBS and ﬁxed with ice-cold 70% ethanol for 10 min  and rehy-
drated with PBS. Cells were then permeabilized with 0.05% Tween
20 and incubated in a blocking solution containing 1% FAFA for
30 min  at 37 ◦C. After blocking, cells were incubated for 2 h at 37 ◦C
with the anti-ABCA-1 antibody (Novus Biologicals 1:250), washed
and labeled with horseradish peroxidase conjugated-secondary
antibody (Novus Biological 1:800) for 90 min  at 4 ◦C. Finally, cells
were stained with 3,3′-diaminobenzidine (DAB) for 3 min  and after
chromogen development, the slides were washed in distilled water
and counterstained with hematoxylin (30 s). The samples were
blindly analyzed, and brownish yellow granular deposits were con-
sidered positive areas. QWin V3 Standard was used to perform
semiquantitative evaluation under a light microscope, and the inte-
grated optical density of the positively stained area was  measured
at a magniﬁcation of 400×. Measurements were taken from 4
random ﬁelds in each slide, and 4 slides were assessed for each
condition. Data were expressed as integrated optical density per
group.
2.7. ABCA-1 mRNA by real time RT-PCR
Total RNA from macrophages treated with C- or AGE-alb was
isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). RNA
quality was assessed using a Bioanalyzer 2100 (Agilent Technolo-
gies, Palo Alto, CA). Real-time RT-PCR was conducted using TaqMan
two step RT-PCR (Applied Biosystems, Foster City, CA, USA). The
following TaqMan Gene Expression Assay was  used: Mouse ABCA-
1 (Mm00442663 m1)  in the Step One Plus Real Time PCR System
(Applied Biosystems, Foster City, CA, USA). The results were cor-
rected to the internal -actin gene (Mm00607939 s1), and relative
quantiﬁcation analysis was performed with StepOne Software 2.0
(Applied Biosystems, Foster City, CA, USA) using the comparative
cycle threshold (Ct) (2−Ct) method.
2.8. LDL isolation and acetylation
Low-density lipoprotein (LDL, d = 1.019–1.063 g/mL) was iso-
lated after sequential preparative ultracentrifugation of fresh
plasma drawn from healthy donors and puriﬁed by discontinuous
gradient ultracentrifugation. After dialysis, the protein concentra-
tion was  measured by the Lowry protocol (Lowry et al., 1951) and
acetylation performed according to Basu et al. (1976),  followed by
extensive dialysis and sterilization in a 0.22 m ﬁlter.
2.9. Cholesterol efﬂux assay
Mouse peritoneal macrophages were cultured in RPMI 1640
containing 10%, penicillin and streptomycin and were maintained
in a 5% CO2 incubator at 37 ◦C. Cells were enriched with acety-
lated LDL (50 g/mL) and 0.3 Ci/mL of 14C-cholesterol (Perkin
Elmer, Boston, MA,  USA) for 48 h. After two  washes with PBS
containing FAFA, cells were maintained for 24 h in DMEM con-
taining FAFA and cAMP, followed by 8 hours of incubation with
2 mg/mL  C- or AGE-alb both in the absence or presence of 5 mM
4-PBA. In some experiments, macrophages were treated with tuni-
camycin (2 g/mL) for 18 h. Macrophages were then incubated with
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Fig. 2. ABCA-1 protein level, but not mRNA, is reduced in macrophages treated with AGE-alb. Macrophages were treated for 8 h with C- or AGE-alb (2 mg/mL). (A) ABCA-1
content was  determined by ﬂow cytometry in J774 macrophages (n = 6) and by (B) immunocytochemistry in mouse peritoneal macrophages (representative images are
shown  below; (n = 4). Inner panel: abca-1 mRNA levels were determined by RT-PCR.
30 g/mL Apo A-I (Sigma Aldrich) for 8 h to determine the 14C-
cholesterol efﬂux, as previously described (Machado et al., 2006).
2.10. Statistical analysis
Statistical analyses were performed using GraphPad Prism 4.0
software (GraphPad Prism, Inc., San Diego, CA), and the Student’s t
test was used to evaluate each group. Summary data are reported
as the mean values ± standard deviation. A p-value <0.05 was  con-
sidered statistically signiﬁcant.
3. Results
Glycolaldehyde-modiﬁed albumin presented an increased ﬂu-
orescence proﬁle regarding total AGE when compared to C-alb
samples (53,330 ± 15,824 vs. 1388 ± 368; p = 0.0047). In addi-
tion, previous studies from our group showed derivatization by
carboxymethyllysine following albumin treatment in the same
conditions as the present investigation (de Souza Pinto et al., 2012).
The carbonyl content was  higher in macrophages incubated with
AGE-alb in comparison to cells treated with C-alb (respectively,
24.11 ± 2.01 and 17.10 ± 1.07 nanomoles of carbonyls per mil-
ligram of protein, n = 4; p = 0.0209).
Mouse peritoneal macrophages treated for 8 h with AGE-alb
displayed increased expression of Grp78, which is considered
a hallmark of ER stress activation (Fig. 1A). A time-dependent
increase in the expression of Grp78 and Grp94 (Fig. 1B and C)
was  observed, with the most substantial increase at 8 hour after
treatment, followed by a slight decrease overtime. At 18 h, AGE-
alb-induced chaperone expression was still much higher compared
to C-alb-treated macrophages. As expected, tunicamycin induced
a 15% and 25% increase in Grp78 and Grp94, respectively. Sim-
ilarly, the expression of ATF6 and eIF2-P was also induced in
a time-dependent manner in macrophages treated with AGE-alb
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Fig. 3. 4-PBA alleviates ER stress and restores ABCA-1 content and Apo A-I-mediated 14C-cholesterol efﬂux. Mouse peritoneal macrophages were treated for 8 hours with
C-  or AGE-alb (2 mg/mL) in the absence or presence of 2.5 or 5.0 mM 4-PBA. Equal amounts of cellular protein were loaded onto a polyacrylamide gel, and electrophoresis
and  immunoblotting were performed to measure the expression of A) Grp78 (n = 3), B) ATF6 (n = 3) and C) eIF2-P (n = 3). Data are expressed as arbitrary units corrected
to  -actin levels. (D) ABCA-1 content was determined by ﬂow cytometry (n = 6) in J774 macrophages and by (E) immunocytochemistry in mouse peritoneal macrophages
(representative images are shown below; n = 4). (F) Acetylated-LDL and 14C-cholesterol enriched-mouse peritoneal macrophages were treated for 8 h with C- or AGE-alb
(2  mg/mL), and cholesterol efﬂux to Apo A-I was assessed (30 g/mL of Apo A-I for 8 h).
(Fig. 1D and E). In agreement to our previous results, follow-
ing an 18 hour-treatment, expression of these UPR markers was
much higher compared to cells exposed to C-alb. No changes
were observed in protein desulﬁde isomerase (PDI) or CHOP
expression when macrophages were exposed to AGE-alb (data not
shown).
Macrophages treated with AGE-alb did not alter the ABCA-
1 mRNA levels when compared with C-alb-treated cells (Fig. 2
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Fig. 4. ER stress elicited by tunicamycin reduces ABCA-1 protein levels and Apo A-
I-mediated cholesterol efﬂux. Mouse peritoneal macrophages were treated for 18 h
with tunicamycin (Tun-2 g/mL), and control incubations were preformed in the
presence of DMEM alone. (A) ABCA-1 content was determined by ﬂow cytometry in
J774 macrophages (n = 6). (B) Acetylated-LDL and 14C-cholesterol enriched-mouse
peritoneal macrophages were treated for 18 h with tunicamycin (2 g/mL), and con-
trol  incubations were preformed in the presence of DMEM alone. Cholesterol efﬂux
was  determined after macrophage incubation with Apo A-I (30 g/mL) for 8 h.
inner panel). However, the ABCA-1 protein level, assessed by ﬂow
cytometry and immunocytochemistry, was reduced by 33% and
25%, respectively, in AGE-alb-treated macrophages compared with
cells treated with C-alb (Fig. 2A and B). Thus, both surface ABCA-
1, as determined by ﬂow cytometry, and total ABCA-1 content, as
assessed by immunocytochemistry, were reduced in macrophages
treated with AGE-alb.
AGE-alb-induced ER stress was alleviated by incubation with
4-PBA, as was demonstrated by the reduction in Grp78 expres-
sion (Fig. 3A). In agreement with this result, the expression of UPR
markers (ATF6 and eIF2-P) was also reduced when macrophages
were incubated with 4-PBA (Fig. 3B and C). Furthermore, 4-PBA
(2.5 mM)  prevented the reduction of ABCA-1 protein levels induced
by AGE-alb (Fig. 3D). These results were conﬁrmed using immuno-
cytochemistry, utilizing 4-PBA at a 5 mM concentration (Fig. 3E).
A 47% reduction in Apo A-I-mediated cholesterol efﬂux was
observed in cells treated with AGE-alb compared to C-alb; how-
ever, in the presence of 5 mM 4-PBA this difference was  no longer
observed between cells treated with AGE-alb and C-alb (Fig. 3F).
These data agree with the recovery of the ABCA-1 protein level
after inhibition of ER stress with 4-PBA. The association between ER
stress and the impairment of cholesterol efﬂux was also conﬁrmed
by incubation with tunicamycin, which reduced ABCA-1 protein
content in 61% (Fig. 4A) and reduced Apo A-I mediated cholesterol
efﬂux by 82% (Fig. 4B).
An exponential increase was observed in the total ubiquitin
content of macrophages treated with AGE-alb over time (Fig. 5A).
Incubation of macrophages with the proteasomal inhibitor, MG132,
was  unable to restore the diminished expression of ABCA-1
(Fig. 5B). Similar results were observed by immunocytochemistry
(Fig. 5C). Therefore, the possibility of a proteasomal-mediated
pathway targeting ABCA-1 degradation in macrophages treated
with AGE-alb was excluded.
4. Discussion
In the setting of hyperglycemia, intracellular cholesterol accu-
mulation, oxidative stress, inﬂammation and the accumulation of
several different metabolites predict the ER stress response, which
has been described as an important contributor to DM complica-
tions (Sage et al., 2010; Alhusaini et al., 2010).
In the present study, we  demonstrated that in macrophages,
AGE-alb induces ER stress, which is related to the impairment
in macrophage RCT. The expression of endogenous chaperones
that aid in proper protein folding, such as Grp78 and Grp94, as
well as UPR mediators, such as ATF-6 and eIF2, was  elevated in
a time-dependent manner in macrophages treated with AGE-alb
compared to C-alb-treated cells, conﬁrming ER-stress induction
under glycoxidative conditions. Macrophage ER stress can be
induced by several intracellular mechanisms elicited by AGE-alb,
including cholesterol accumulation, inﬂammation and oxidative
stress.
Oxoaldehydes such as GAD are generated in inﬂammatory reac-
tions, speciﬁcally mediated by the myeloperoxidase system. This
can contribute to GAD generation in atherosclerotic lesions and
to the local modiﬁcation of albumin and other macromolecules.
In addition, CML  adducts have been found in atherosclerotic
lesions from diabetic and dyslipidemic humans and animal models
(Anderson et al., 1999).
ER membranes are highly sensitive to free cholesterol accumu-
lation, which leads to cytotoxic effects in cells (Feng et al., 2003). In
this regard, it has previously been shown by our group and others
that AGE-alb treatment reduces the expression of both ABCA-1 and
ABCG-1, impairing Apo A-I and HDL-mediated cholesterol efﬂux
and leading to intracellular cholesterol accumulation (de Souza
Pinto et al., 2012; Machado et al., 2006).
We previously identiﬁed a reduction in ABCA-1 macrophage
content in response to both AGE-alb and serum albumin isolated
from poorly controlled diabetes mellitus patients (Machado-Lima
et al., 2010). This was  related to the oxidative stress elicited by AGE-
albumin via NADPH oxidase and by the mitochondrial respiratory
chain (de Souza Pinto et al., 2012) and also to the accumulation of 7-
ketocholesterol that has been found in glycoxidized macrophages
(Iborra et al., 2011).
Moreover, AGE-alb induces the expression of the receptor for
advanced glycation end-products (RAGE) and scavenger recep-
tors involved in the uptake of modiﬁed LDL by macrophages
(Iwashima et al., 2000). RAGE activation elicits NADPH oxidase
activation and the production of ROS, which ultimately lead to NF-
B activation and the transcription of inﬂammatory genes (Basta
et al., 2005). Inﬂammation contributes considerably to atheroge-
nesis and also triggers ER stress via JNK activation (Hotamisligil,
2010; Hetz et al., 2006). Unpublished data from our group indi-
cate that in macrophages, endotoxin-free AGE-alb primes these
cells for an inﬂammatory response elicited by S100B calgranulins
or lipopolysaccharides, which then damages the cholesterol efﬂux.
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Fig. 5. Proteasomal inhibition by MG132 is unable to restore ABCA-1 content in macrophages treated with AGE-alb. (A) Mouse peritoneal macrophages were treated for
different periods of time with C- or AGE-alb (2 mg/mL). Equal amounts of cellular protein were loaded onto polyacrylamide gels, and electrophoresis and immunobloting
were performed to measure the expression of ubiquitin. (B) Macrophages were treated for 8 h with C- or AGE-alb (2 mg/mL) in the absence or presence of the proteasomal
inhibitor MG132 (1 M).  ABCA-1 content was determined by ﬂow cytometry in J774 macrophages (n = 6) and by (C) immunocytochemistry in mouse peritoneal macrophages
(n  = 4).
Aside from the observed increase in ATF6 expression in
macrophages treated with AGE-alb, we did not ﬁnd any alterations
in CHOP expression. In agreement, cellular apoptosis, assessed by
Annexin V, was not different between cells treated with C- and
AGE-alb (data not shown).
The level of ABCA-1 protein was reduced by 33% in macrophages
treated with AGE-alb, and treatment with 4-PBA was able to com-
pletely restore ABCA-1 levels and Apo A-I-mediated cholesterol
efﬂux in macrophages. The chemical chaperone 4-PBA is known to
improve ER folding capacity and to facilitate the trafﬁcking of mis-
folded proteins. These effects help to prevent protein aggregation
stabilizing their conformation (Engin and Hotamisligil, 2010). In
diabetic and obese animal models, Ozcan et al. (2006) have shown
that oral administration of 4-PBA was  able to normalize plasma glu-
cose levels and restore systemic insulin sensitivity, separate from
other anti-diabetic effects that were observed even in the absence
of body weight loss.
The association between ER stress and ABCA-1 reduction, which
has not been described so far, was  further strengthened by the
ﬁnding that tunicamycin – a classical ER stress inductor – also
diminishes ABCA-1 and cholesterol efﬂux.
We have also obtained preliminary data demonstrating that
aminoguanidine (an antioxidant and anti-AGE compound) dimin-
ishes the AGE-alb-induced expression of Grp78. Aminoguanidine is
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able to reduce the generation of ROS in macrophages treated with
AGE-alb and also recovers ABCA-1 protein content (de Souza Pinto
et al., 2012). Thus, in our experimental conditions, ER stress is the
most likely phenomenon linking the redox imbalance to the reduc-
tion in ABCA-1 levels in macrophages under glycoxidative stress,
especially considering the important role this organelle plays in
protein synthesis/stability.
Since ERAD is part of the UPR, speciﬁcally mediated by the IRE1
and ATF6 branches, and targets misfolded proteins for degradation
(Kincaid and Cooper, 2007), we investigated whether inhibition of
the proteasome had any effect on ABCA-1 protein levels in AGE-
alb-treated macrophages. We  found that proteasome inhibition by
MG132 was not able to prevent the ABCA-1 reduction in AGE-
alb-treated macrophages. In addition, the elevated level of total
ubiquitin found in macrophages suggests proteasomal inhibition
according to recent ﬁndings. Moheimani et al. (2010) demon-
strated an impairment in the activity of proteasomal enzymes in
macrophages incubated with GAD-modiﬁed albumin, suggesting a
deleterious effect of oxoaldehydes in the intracellular accumulation
of misfolded and glycated proteins in diabetes mellitus. Nonethe-
less, the concentration of albumin utilized per milliliter of cell
medium was highly superior when compared to that utilized by us
(4 mg/mL  vs. 2 mg/mL, respectively). Also, AGE-alb increases gen-
eration of ROS due to mitochondrial dysfunction (de Souza Pinto
et al., 2012) and considering that the ubiquitin–proteasome com-
plex is a high energy requiring system, the damage in mitochondrial
function, induced by AGE, may  contribute to the impairment in
proteasomal activity.
Together with the observation that MG132 does not recover
ABCA-1 levels, we assume that AGE-alb already damages the pro-
teasomal system, which excludes the role of ERAD in ABCA-1
reduction in AGE-treated cells.
Zelcer et al. (2009) previously reported a proteasome-
independent pathway for LDL-receptor (B-E receptor) degradation.
In agreement with their ﬁndings, our experimental conditions
showed that ABCA-1 levels do not appear to be regulated by
ERAD/ubiquitin-proteasomal degradation. ABCA-1 is a large and
complex polypeptide, and a wide range of posttranslational modi-
ﬁcations carried out by ER machinery are required to reach a ﬁnal
mature conformation. Alteration of one or more of these mecha-
nisms could impair the ABCA-1 structure and functionality (Kang
et al., 2010).
Our study describes, for the ﬁrst time, the effect of AGE-alb on
macrophage ER stress, which is indeed associated with ABCA-1
content and function impairment in diabetes mellitus. The exact
mechanism by which ER stress affects ABCA-1 content remains elu-
sive and requires further investigation. ER dysfunction appears to
play an important role in a wide range of diseases, including obe-
sity, hepatic steatosis and DM (Hotamisligil, 2010). In this regard,
chemical chaperones, such as 4-PBA, represent an exciting area of
research for clinical application and may  contribute to the preven-
tion of atherosclerosis in DM.
5. Conclusion
In conclusion, in diabetes mellitus and other carbonyl stress
conditions, despite modiﬁcations in the lipoprotein chemical com-
position and concentration, advanced glycated albumin contributes
to atherogenesis by inducing ER dysfunction, which relates to the
reduction in ABCA-1-mediated macrophage reverse cholesterol
transport.
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